[Treatment of myasthenia gravis pseudoparalytica. Analysis of 60 personal cases and study of the literature].
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy*; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009388:Neostigmine / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
D009388:Neostigmine; D000324:Adrenocorticotropic Hormone; D011729:Pyridostigmine Bromide
Il trattamento della miastenia grave pseudoparalitica. Analisi di 60 casi personali e studio della letteratura